| 期刊論文| 1. | 江文秀、徐苑綺、李若瑜、王春葉、李建德(20090800)。經皮血管成型術(PTA)於動靜脈瘻管阻塞之應用與照護。腎臟與透析，21(3)，177-181。 延伸查詢 | | 2. | 賴奇正、葉同成、林俊堯、許智揚、蕭世宏、馬光遠、劉俊鵬(20080600)。長期血液透析瘻管失能的處置。內科學誌，19(3)，197-204。 延伸查詢 | | 3. | Ross, R.(1993)。The pathogenesis of atherosclerosis: a perspective for the 1990s。Nature，362(6423)，801-809。  | | 4. | Ross, R.(1999)。Atherosclerosis: An Inflammatory Disease。The New England Journal of Medicine，340(2)，115-126。 | | 5. | Lazarides, M. K.、Georgiadis, G. S.、Antoniou, G. A.、Staramos, D. N.(2007)。A meta-analysis of dialysis access outcome in elderly patients。Journal of Vascular Surgery，45(2)，420-426+e2。 | | 6. | 林信昌(20051100)。血液透析病人動靜脈瘻管功能不良的監測及治療。腎臟與透析，17(4)，196-197。 延伸查詢 | | 7. | 洪燕妮、吳肖琪、吳義勇、柯博仁(20090400)。採用動靜脈瘻管或人工血管之血液透析病人住院醫療利用之分析。臺灣公共衛生雜誌，28(2)，144-154。 延伸查詢 | | 8. | Saran, R.、Elder, SJ.、Goodkin, DA. et al.(2008)。Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients:results from the Dialysis Outcomes and Practice Patterns Study。Annals of Surgery，247(5)，885-891。 | | 9. | 許智揚(2008)。透析病志血管通路的建立及維護。腎臟與透析，20(2)，63-67。 延伸查詢 | | 10. | Ascher, E.、Hingorani, A.(2004)。The Dialysate Outcome and Quality Intiative (DOQI) recommendations。Seminars in Vascular Surgery，17(1)，3-9。 | | 11. | Chen, C.、Lumsden, A. B.、Ofenloch, J. C.、Noe, B.、Campbell, E. J.、Stratford, P. W.、Yianni, Y. P.、Taylor, A. S.、Hanson, S. R.(1997)。Phosphorylcholine coating of ePTFE graft reduces neointimal hyperplasia in canine model。Annals of Vascular Surgery，11(1)，74-79。 | | 12. | Chen, S. C.、Chang, J. M.、Hwang, S. J.、Tsai, J. C.、Wang, C. S.、Mai, H. C.、Lin, F. H.、Su, H. M.、Chen, H. C.(2009)。Significant correlation between ankle-brachial index and vascular access failure in hemodialysis patients。Clinical Journal of the American Society of Nephrology，4(1)，128-134。 | | 13. | Chiu, B.、Viira, E.、Tucker, W.、Fong, I. W.(1997)。Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery。Circulation，96(7)，2144-2148。 | | 14. | Churchill, D. N.、Taylor, D. W.、Cook, R. J.、LaPlante, P.、Barre, P.、Cartier, P.、Fay, W. P.、Goldstein, M. B.、Jindal, K.、Mandin, H.(1992)。Canadian Hemodialysis Morbidity Study。American Journal of Kidney Disease，19(3)，214-234。 | | 15. | Deighan, C. J.、Caslake, M. J.、McConell, M.、Boulton-Jones, J. M.、Packard, C. J.(2000)。Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation。American Journal of Kidney Disease，35(5)，852-862。 | | 16. | Grandaliano, G.、Teutonico, A.、Allegretti, A.、Losappio, R.、Manini, A.、Gesualdo, L.、Schena, F. P.、Pertosa, G.(2003)。The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis。Kidney International，64(2)，715-719。 | | 17. | Gotch, F. A.(2001)。Evolution of the single-pool urea kinetic model。Seminars in Dialysis，14(4)，252-256。 | | 18. | Hayakawa, K.、Miyakawa, S.、Hoshinaga, K.、Hata, K.、Marumo, K.、Hata, M.(2007)。The effect of patient age and other factors on the maintenance of permanent hemodialysis vascular access。Therapeutic Apheresis and Dialysis，11(1)，36-41。 | | 19. | Hofstra, L.、Bergmans, D. C.、Leunissen, K. M.、Hoeks, A. P.、Kitslar, P. J.、Tordoir, J. H.(1996)。Prosthetic arteriovenous fistula and venous anastomotic stenosis: influence of a high flow velocity on the development of intimai hyperplasia。Blood Purify，14(5)，345-349。 | | 20. | Hofstra, L.、Tordoir, J. H.、Kitslar, P. J.、Hoeks, A. P.、Daemen, M. J.(1996)。Enhanced cellular proliferation in intact stenotic lesion derived from human arteriovenous fistula and peripheral bypass graft。Circulation，94(6)，1283-1290。 | | 21. | Kim, B. S.、Jeon, D. S.、Shin, M. J.、Kim, Y. O.、Song, H. C.、Lee, S. H.,、Kim, S. Y.、Choi, E. J.、Cang, Y. S.、Bang, B. K.(2005)。Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patient maintained on hemodialysis。American Journal of Kidney Disease，25(3)，189-195。 | | 22. | Mariko, E.、Kazufumi, T.、Hideki, T.、Narifumi, N.、Makoto, H.、Hirofumi, O.、Taka-aki, T.、Akiyoshi, H.、Shigeru, M.、Tomoaki, N.、Nobuyuki, U.、Kazuaki, S.(2000)。Detection of cardiac calcinosis in hemodialysis patients by whole-body scintigraphy with 99m-technetium methylene diphosphonate。American Journal of Nephrology，20(4)，278-282。 | | 23. | Matsumae, T.、Abe, Y.、Murakami, G.、Ishihara, M.、Ueda, K.、Saito, T.(2007)。Determinants of arterial wall stiffness and peripheral artery occlusive disease in nondiabetic hemodialysis patients。Hypertension Research，30(5)，377-385。 | | 24. | Maya, I, D.、Weatherspoon, J.、Young, C. J.、Barker, J.、Allon, M.(2007)。Increased risk of infection associated with polyurethane dialysis graft。Seminars in Dialysis，20(6)，616-620。 | | 25. | Nishizawa, Y.、Shoji, T.、Emoto, M.、Koyama, H.、Tahara, H.、Fukumoto, S.、Inaba, M.、Ishimura, E.、Miki, T.(2004)。Roles of metabolic and endocrinological alterations in artherosceler-osis and cardiovascular disease in renal failure: another form of metabolic syndrome。Seminar in Nephrology，24(5)，423-425。 | | 26. | O’Hare A. M.、Hsu, C. Y.、Bacchetti, P.、Johansen, K. L.(2002)。Peripheral vascular disease risk factors among patients undergoing hemodialysis。Journal of the American Society of Nephrology，13(2)，497-503。 | | 27. | Puskar, D.、Pasini, J.、Savic, I.、Bedalov, G.、Sonicki, Z.(2002)。Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis。Croatian Medical Journal，43(3)，306-311。 | | 28. | Schwab, S. J.、Harrigton, J. T.、Singh, A.、Roher, R.、Shohaib, S. A.、Perrone, R. D.、Meyer, K.、Beasley, D.(1999)。Vascular access for hemodialysis。Kidney International，55(5)，2078-2090。 | | 29. | Weiss, M. F.、Scivittaro, V.、Anderson, J. M.(2001)。Oxidative stress and increased expression of growth factors of failed hemodialysis access。American Journal of Kidney Disease，37(5)，970-980。 | 圖書| 1. | John, T.、Peter, G.、Todd, S.、陳鴻鈞、陳忠祺(2007)。透析手冊：血液透析的動靜脈瘻管通路。台北：力大。 延伸查詢 | 其他| 1. | Lazarus, J. M., Lowrie, E. G., Hampers, C. L., & Merrill, J. P.(1975)。Cardiovascular disease in uremic patients on hemodialysis。 | |
| |